Health Condition 1: C069- Malignant neoplasm of mouth, unspecified
Conditions
Interventions
Intervention1: Centella asiatica: Centella asiatica mouthwash, gel and chewable tablet will be prepared and delivered to patients with non homogenous leukoplakia for 21 days.Review will be done in 7 d
Sponsors
Ashmi Grace Abraham
Eligibility
Inclusion criteria
Inclusion criteria: Patients clinically and/or histopathologically diagnosed with non-homogenous oral leukoplakia Patients willing to discontinue oral habits and provide informed consent. Patients willing to comply with the study protocol and follow-up.
Exclusion criteria
Exclusion criteria: Patients with oral squamous cell carcinoma Patients who received treatment for non-homogenous OL within the last 3 months Pregnant or lactating women History of hypersensitivity to herbal drugs Unwilling or non-compliant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the therapeutic efficacy of Centella asiatica on non-homogenous oral leukoplakia.Timepoint: Baseline, 7 days and 21 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of Centella asiatica on non-homogenous oral leukoplakia.Timepoint: Baseline, 7 days and 21 days;To compare the effectiveness of Centella asiatica in non-homogenous oral leukoplakia in various administration forms Gel, Mouthwash and Chewable tablet.Timepoint: Baseline, 7 days and 21 days | — |
Countries
India
Contacts
Public ContactDrJayaprasad Anekar
KVG Dental College and Hospital
Outcome results
None listed